Gain-of-function mutations, such as RHO gene mutations causing retinitis pigmentosa (RP), can induce the production of cytotoxic proteins and dominant-negative mutations, like RP1 variants in RP, and can lead to the expression of mutated proteins that impair the function of the wild type protein. Here, RHO is linked to retinitis pigmentosa 1.